Several companies, under investigation for presumably conspiring to manipulate the allocation of several contracts for carrying out clinical tests for Mexico’s Social Security Institute (IMSS), have been found to be participating in two ongoing contract bids. The IMSS is close to determining the winners in a series of multi-annual contracts, worth over 3 billion pesos ($200 million US approx), to run the Institute’s blood bank services. A second contract worth at least $2.7 billion pesos (150 million US) for the performance of non-invasive surgeries is also ongoing.
Telephone conversations leaked on Youtube revealed an alleged agreement between high-ranking officials at Falcón Medical Instruments and Centrum Promotora Internacional to divide the clinical study contracts between them and other companies. The situation prompted the IMSS to request Mexico’s competition watchdog, COFECE, to investigate.
The two companies, along with Selecciones Medicas del Centro, Dicipa, Hemoser and Impromed, have long dominated this kind of medical contract. These companies are also among those seeking to obtain one of the up to 18 regional contracts currently up for bidding.
Full content: Zócalo
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI